Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Atorvastatin Glucuronidation Is Minimally and Nonselectively Inhibited by the Fibrates Gemfibrozil, Fenofibrate, and Fenofibric Acid

Theunis C. Goosen, Jonathan N. Bauman, John A. Davis, Chongwoo Yu, Susan I. Hurst, J. Andrew Williams and Cho-Ming Loi
Drug Metabolism and Disposition August 2007, 35 (8) 1315-1324; DOI: https://doi.org/10.1124/dmd.107.015230
Theunis C. Goosen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan N. Bauman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John A. Davis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chongwoo Yu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan I. Hurst
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Andrew Williams
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cho-Ming Loi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 35 no. 8 1315-1324
DOI 
https://doi.org/10.1124/dmd.107.015230
PubMed 
17470524

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received February 16, 2007
  • Accepted April 25, 2007
  • Published online July 19, 2007.

Article Versions

  • Earlier version (April 30, 2007 - 07:22).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Theunis C. Goosen,
  2. Jonathan N. Bauman,
  3. John A. Davis1,
  4. Chongwoo Yu2,
  5. Susan I. Hurst,
  6. J. Andrew Williams and
  7. Cho-Ming Loi
  1. Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer Global Research and Development, Ann Arbor, Michigan
  1. Address correspondence to:
    Dr. Theunis C. Goosen, Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer Global Research and Development, 2800 Plymouth Rd., Ann Arbor, MI 48105. E-mail: theunis.goosen{at}pfizer.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to November 2023

AbstractFullPdf
Aug 201723019
Sep 20173259
Oct 201706813
Nov 201734629
Dec 20171275
Jan 201804114
Feb 201874816
Mar 201825815
Apr 201824121
May 201835022
Jun 201822612
Jul 201812320
Aug 20180197
Sep 201803919
Oct 201803217
Nov 201802926
Dec 2018231017
Jan 201912717
Feb 20191945
Mar 20192937
Apr 20193346
May 201912812
Jun 20191428
Jul 20192658
Aug 20191787
Oct 20193278
Nov 20191879
Dec 20193663
Jan 20206012
Feb 20201721
Mar 2020736
May 20201832
Jun 20201311
Jul 20201722
Aug 20201914
Sep 20201825
Oct 20202643
Nov 20201724
Dec 20201615
Jan 20212372
Feb 202131103
Mar 20212962
Apr 20211211
May 20213427
Jun 20211651
Jul 20211745
Aug 20211467
Sep 20212563
Oct 20212830
Nov 20213057
Dec 20213126
Jan 20223315
Feb 202223710
Mar 20221813
Apr 20222174
May 20223021
Jun 20224541
Jul 202237311
Aug 20224132
Sep 20222111
Oct 20221943
Nov 202232136
Dec 20221546
Jan 20234652
Feb 20232525
Mar 20233031
Apr 20231856
May 20233227
Jun 20232620
Jul 20232877
Aug 2023779
Sep 20232363
Oct 202331129
Nov 202315103

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 35 (8)
Drug Metabolism and Disposition
Vol. 35, Issue 8
1 Aug 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Atorvastatin Glucuronidation Is Minimally and Nonselectively Inhibited by the Fibrates Gemfibrozil, Fenofibrate, and Fenofibric Acid
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Atorvastatin Glucuronidation Is Minimally and Nonselectively Inhibited by the Fibrates Gemfibrozil, Fenofibrate, and Fenofibric Acid

Theunis C. Goosen, Jonathan N. Bauman, John A. Davis, Chongwoo Yu, Susan I. Hurst, J. Andrew Williams and Cho-Ming Loi
Drug Metabolism and Disposition August 1, 2007, 35 (8) 1315-1324; DOI: https://doi.org/10.1124/dmd.107.015230

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Atorvastatin Glucuronidation Is Minimally and Nonselectively Inhibited by the Fibrates Gemfibrozil, Fenofibrate, and Fenofibric Acid

Theunis C. Goosen, Jonathan N. Bauman, John A. Davis, Chongwoo Yu, Susan I. Hurst, J. Andrew Williams and Cho-Ming Loi
Drug Metabolism and Disposition August 1, 2007, 35 (8) 1315-1324; DOI: https://doi.org/10.1124/dmd.107.015230
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Cytochrome P450 4F11 in lung cancer
  • SLC49A4-mediated pyrilamine transport
  • IVIVE of Aldehyde Oxidase-Mediated Clearance
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics